11:04 AM
 | 
Aug 08, 2018
 |  BC Extra  |  Company News

Samsung planned $22B investment includes biopharma, AI

Samsung Group (Seoul, South Korea) said it would invest W25 trillion ($22.2 billion) over the next three years in biopharmaceuticals and artificial intelligence, among other...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >